Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience

This study aimed to evaluate the efficacy and safety of the fludarabine-cyclophosphamide-rituximab regimen for young physically fit patients with chronic lymphocytic leukemia in the “real-life” setting. We specifically focused on the impact of dose reduction on patient outcomes. The patient cohort c...

Full description

Saved in:
Bibliographic Details
Published in:Haematologica
Main Authors: Herishanu, Yair, Goldschmidt, Neta, Bairey, Osnat, Ruchlemer, Rosa, Fineman, Riva, Rahimi-Levene, Naomi, Shvidel, Lev, Tadmor, Tamar, Ariel, Aviv, Braester, Andrea, Shapiro, Mika, Joffe, Erel, Polliack, Aaron
Format: Artigo
Language:Inglês
Published: Ferrata Storti Foundation 2015
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420215/
https://ncbi.nlm.nih.gov/pubmed/25661442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.115808
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items